UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Esperion Therapeutics is implementing good security practices.
Esperion Therapeutics, Inc. is a public, American pharmaceutical company focused on the development of a first-in-class, orally available, small molecule designed to significantly lower elevated levels of LDL-C - with the reduced potential for muscle-related side effects associated with statin use.
This report shows a preliminary security rating for Esperion Therapeutics. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Vendor risk management (VRM) deals with the management and monitoring of risks resulting from ...
Operations security (OPSEC) is a process that identifies friendly actions that could be useful for ...
Compare Esperion Therapeutics's security performance with other companies